Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 2,730,000 shares, a drop of 14.7% from the November 30th total of 3,200,000 shares. Based on an average daily volume of 406,000 shares, the days-to-cover ratio is currently 6.7 days.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a research note on Friday, September 27th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. DA Davidson restated a “buy” rating and set a $32.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Finally, JPMorgan Chase & Co. raised their target price on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, September 9th. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $29.33.

Phreesia Price Performance

Shares of NYSE:PHR remained flat at $25.76 during midday trading on Friday. 242,154 shares of the stock were exchanged, compared to its average volume of 448,706. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average of $21.30 and a 200 day moving average of $22.18. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of -17.52 and a beta of 0.98. Phreesia has a 12-month low of $17.07 and a 12-month high of $29.16.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. On average, research analysts predict that Phreesia will post -1.16 EPS for the current year.

Insider Activity at Phreesia

In other news, SVP David Linetsky sold 2,011 shares of the company’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $42,291.33. Following the completion of the transaction, the senior vice president now directly owns 201,307 shares in the company, valued at approximately $4,233,486.21. This represents a 0.99 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total value of $25,488.36. Following the transaction, the general counsel now directly owns 119,791 shares in the company, valued at approximately $2,519,204.73. This represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 90,342 shares of company stock valued at $2,041,225 over the last three months. 5.80% of the stock is owned by corporate insiders.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently bought and sold shares of PHR. International Assets Investment Management LLC grew its holdings in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares during the last quarter. nVerses Capital LLC increased its holdings in shares of Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after purchasing an additional 1,300 shares in the last quarter. Lombard Odier Asset Management USA Corp purchased a new position in shares of Phreesia in the second quarter worth $202,000. Point72 DIFC Ltd bought a new position in shares of Phreesia during the second quarter valued at $209,000. Finally, XTX Topco Ltd bought a new stake in Phreesia in the 3rd quarter worth about $247,000. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.